Saunders J, Hall S E, Sönksen P H
Clin Endocrinol (Oxf). 1980 Jul;13(1):33-44. doi: 10.1111/j.1365-2265.1980.tb01020.x.
Glucose and free fatty acid (FFA) turnover (RT) were measured by isotopic methods in groups of patients with thyrotoxicosis and hypothyroidism and compared with normal subjects. Patients with thyrotoxicosis were then studied after treatment with oral propranolol and again after treatment with carbimazole. Patients with hypothyroidism were studied again after treatment with thyroxine. Glucose RT was increased by about a third in thyrotoxicosis (12.7 mumol. min.-1 kg-1 +/- 1.0 SEM compared to 9.5 +/- 0.5 in normal subjects) while FFA RT was doubled (12.5 mumol. min.-1 kg-1 +/- 1.2 compared to 6.3 +/- 0.9 in normals). Propranolol was without effect, but carbimazole normalized these variables. In hypothyroidism both glucose and FFA RT were normal (9.1 +/- 0.7 and 6.7 +/- 0.9 respectively). Mean glucose and FFA RT both rose following thyroxine treatment, but not significantly; the post-treatment values remaining within the normal range (10.3 +/- 0.7 and 7.0 +/- 1.3 respectively). Oxidation of FFA, as estimated by 14CO2 excretion, was increased in thyrotoxicosis (42.8% +/- 2.9 SEM compared to 34.8 +/- 2.3 in normal subjects) and fell with carbimazole treatment (34.7 +/- 4.1). In hypothyroid subjects FFA oxidation increased following thyroxine treatment (from 34.4 +/- 4.1). In hypothyroid subjects FFA oxidation increased following thyroxine treatment (from 34.4 +/- 3.3 to 46.2 +/- 3.6).
采用同位素方法测定了甲状腺毒症和甲状腺功能减退患者组的葡萄糖和游离脂肪酸(FFA)周转率(RT),并与正常受试者进行比较。然后,对甲状腺毒症患者分别进行口服普萘洛尔治疗后以及卡比马唑治疗后的研究。对甲状腺功能减退患者进行甲状腺素治疗后的再次研究。甲状腺毒症患者的葡萄糖RT增加了约三分之一(12.7μmol·min⁻¹·kg⁻¹±1.0标准误,而正常受试者为9.5±0.5),而FFA RT增加了一倍(12.5μmol·min⁻¹·kg⁻¹±1.2,正常人为6.3±0.9)。普萘洛尔无效,但卡比马唑使这些变量恢复正常。甲状腺功能减退时,葡萄糖和FFA RT均正常(分别为9.1±0.7和6.7±0.9)。甲状腺素治疗后,葡萄糖和FFA RT的平均值均升高,但无显著差异;治疗后的值仍在正常范围内(分别为10.3±0.7和7.0±1.3)。通过¹⁴CO₂排泄估算的FFA氧化在甲状腺毒症时增加(42.8%±2.9标准误,正常受试者为34.8±2.3),卡比马唑治疗后下降(34.7±4.1)。甲状腺功能减退受试者甲状腺素治疗后FFA氧化增加(从34.4±3.3增至46.2±3.6)。